OAR's Coordinating Role
The National Institutes of Health (NIH) provide leadership in setting the national and global HIV/AIDS research agenda. NIH’s leadership and investment have helped to chart a course that has changed the face of the pandemic.
The NIH response to the HIV/AIDS pandemic requires a unique and complex multidisciplinary research program that transcends every area of clinical medicine and basic scientific investigation and crosses the boundaries of nearly every Institute and Center (IC). OAR was established by Congressional legislation in 1988 to enhance NIH collaboration, minimize duplication, and ensure that research funds are invested effectively and efficiently across the ICs conducting HIV/AIDS research. In this unique role, OAR coordinates the scientific, budgetary, legislative, and policy elements of the NIH HIV/AIDS research program to develop new tools in the national and international fight against AIDS.
OAR also convenes representatives from the NIH ICs, scientists in the field, and community stakeholders to identify the highest priority areas of scientific opportunity and establish the NIH research priorities for HIV/AIDS. The priorities address prevention, treatment, and developing a cure, as well as the management of comorbidities and health complications common in people living with HIV.
Finally, OAR oversees the NIH Coordinating Committees for each of the HIV/AIDS research scientific priorities. The Coordinating Committees provide input during the annual strategic planning and budgeting process, as well as in the development of special initiatives. These committees consist of NIH intramural scientists and extramural health scientists from ICs with major HIV/AIDS research portfolios in each of the specific areas.
NIH AIDS Executive Committee
The NIH AIDS Executive Committee (NAEC) is designed to facilitate communication among OAR and ICs that utilize HIV/AIDS funding. NAEC members include a designated AIDS Coordinator from each IC appointed by its respective Director. The AIDS Coordinators collaborate with OAR to monitor each IC’s HIV/AIDS portfolio and budget, and to share information about other relevant HIV/AIDS activities.
This page last reviewed on February 12, 2020